Genetic disruptions of the Cullin3 complex found in lung cancer patients, at both copy number and gene expression levels, lead to upregulation of IKKβ protein levels and activation of the NF-κB signaling pathway [13]. Here, NFKB1 is linked to lung carcinoma.